13F-HR filed by Squadron Capital Management LLC
Squadron Capital Management LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 37 holding rows worth $272,917,617.
- Accession
- 0002050709-26-000017
- Filer
- CIK 2050709
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 37 entries on the cover page, a total value of $272,917,617 stated on the cover page (in dollars after the unit check, H1), rows summing to $272,917,617 with VALUE read as dollars as filed, 13F file number 028-26573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 8,474,571 | $58,983,014 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 787,492 | $30,310,567 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 985,100 | $19,830,063 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 380,000 | $14,485,600 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 130,000 | $14,475,500 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 350,000 | $11,025,000 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 125,000 | $8,993,750 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 1,265,231 | $8,755,398 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 3,631,000 | $8,496,540 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 257,500 | $7,686,375 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 7,608,695 | $6,976,412 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 672,500 | $6,691,375 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 315,000 | $6,340,950 | dollars as filed | call |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 2,250,000 | $5,917,500 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 3,500,000 | $5,880,000 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 3,000,000 | $5,250,000 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 680,000 | $4,923,200 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 325,000 | $4,569,500 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 750,000 | $4,177,500 | dollars as filed | put |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 324,977 | $4,127,208 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 120,000 | $3,998,400 | dollars as filed | put |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 450,000 | $3,595,500 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 104,300 | $3,475,276 | dollars as filed | call |
| INVENTIVA SA | 46124U107 | ADS | 535,000 | $2,969,250 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,460,000 | $2,927,300 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,100,000 | $2,882,000 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 265,000 | $2,830,200 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 110,000 | $2,537,700 | dollars as filed | call |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 31,000 | $2,455,820 | dollars as filed | |
| PASITHEA THERAPEUTICS CORP | 70261F202 | COM NEW | 2,100,000 | $1,557,780 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 150,000 | $1,492,500 | dollars as filed | call |
| TRAWS PHARMA INC | 68232V884 | COM NEW | 511,714 | $936,437 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 400,000 | $936,000 | dollars as filed | call |
| THERAPEUTICSMD INC | 88338N206 | COM NEW | 420,421 | $849,250 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 12,200 | $797,270 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 563,535 | $469,199 | dollars as filed | |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | COM | 76,728 | $312,283 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002050709-26-000017 | this filing | 2026-05-15 | acceptance time not in the bulk data set |